3 not yet recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 3 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Luvometinib: new trials by email Literature Review of Luvometinib trials Research Report on Luvometinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Luvometinib in Combination With Serplulimab for NF2-Related Tumors Luvometinib, Serplulimab - NF2-related Schwannomatosis, NF2 | Phase 1 / Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 30 | 2026-07-31 | 2026-07-16 |
| Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2) Selumetinib 25mg/m2, Luvometinib, Serplulimab - Neurofibromatosis Type 2, Vestibular Schwannoma | Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 200 | 2026-07-18 | 2026-07-20 |
| Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis Luvometinib, Luvometinib, Cytarabine. - Langerhans Cell Histiocytosis | Phase 2 | Not yet recruiting | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 30 | 2026-06-30 | 2026-07-27 |
Meningioma (2) · Neurofibromatosis 2 (2) · Neuroma, Acoustic (2) · Ependymoma (1) · Histiocytosis, Langerhans-Cell (1)
Beijing Tiantan Hospital (2) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)
China (3)